Guo Chao Chen

Ms. Guo Chao Chen


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2018 in Molecules
Verified
Journal Article
Open access
PDF file
YGYanyan Gao
Yanyan Gao
YJYue Jiang
Yue Jiang
GCGuo Chao Chen
Guo Chao Chen
SLShuang-Shuang Li
Shuang-Shuang Li
FYFei Yang
Fei Yang
QMQun Ma
Qun Ma
Background: Allergic disease is a common clinical disease. Natural products provide an important source for a wide range of potential anti-allergic agents. This study was designed to evaluate the anti-allergic activities of the water-soluble polysaccharides extracted and purified from Saposhnikoviae Radix (SRPS). The composition and content of monosaccharides were determined to provide a material basis. Methods: An ultra-high-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) method was established to determine the composition and content of SRPS. 2,4-dinitrofluorobenzene (DNFB) induced a delayed-type hypersensitivity (DTH) mouse model orally administrated SRPS for seven consecutive days. Ear swelling, organ index, and serum IgE levels were observed to evaluate the anti-allergic activities. Results: The UPLC-MS/MS analysis showed that SRPS was consisted of eight monosaccharides including galacturonic acid, mannose, glucose, galactose, rhamnose, fucose, ribose, and arabinose with a relative molar ratio of 4.42%, 7.86%, 23.69%, 12.06%, 3.10%, 0.45%, 0.71%, and 47.70%, respectively. SRPS could effectively reduce ear swelling, a thymus index, and a serum IgE levels. Conclusions: The method was simple, rapid, sensitive, and reproducible, which could be used to analyze and determine the monosaccharide composition of SRPS. The vivo experiments demonstrated that SRPS may effectively inhibit development of DNFB-induced DTH. SRPS is a novel potential resource for natural anti-allergic drugs.

13 January 2022 in BioMed Research International
Verified
Journal Article
Open access
PDF file
GCGuo Chao Chen
Guo Chao Chen
WZWanqiao Zhang
Wanqiao Zhang
LKLingbo Kong
Lingbo Kong
CWChengxiang Wang
Chengxiang Wang
XLXiaojing Lai
Xiaojing Lai
QMQun Ma
Qun Ma
Pseudomonas aeruginosa (PA), a Gram‐negative bacterium, has a high detection rate in hospital‐acquired infections. Recently, the frequent appearance of multidrug‐resistant (MDR) PA strain with high morbidity and mortality rates has aggravated the difficulty in treating infectious diseases. Due to its multiple resistance mechanisms, the commonly used antibiotics have gradually become less effective. Qiguiyin decoction (QGYD) is a clinically experienced prescription of Chinese herbal medicine, and its combined application with antibiotics has been confirmed to be effective in the clinical treatment of MDR PA infection, which could be a promising strategy for the treatment of drug‐resistant bacterial infections. However, the mechanism of QGYD restoring antibiotics susceptibility to MDR PA remains unclear. In the present study, we investigated the effects of QGYD and levofloxacin (LEV) singly or in combination on MDR PA‐induced pneumonia rat models. Further analysis was carried out in the serum differential expression profiles of inflammatory cytokines by cytokine antibody array. Besides, the lung TLR4/MyD88/NF‐κB signaling pathway was detected by RT‐qPCR. Our results showed that based on the treatment of MDR PA‐infected rat model with LEV, the combination of QGYD improved the general state and immune organ index. Furthermore, it moderately increased the expressions of proinflammatory cytokines including IL‐1β, IL‐6, and TNF‐α in the early stage of infection and decreased their release rapidly in the later stage, while regulated the same phase change of anti‐inflammatory cytokine IL‐10. In addition, the adhesion molecule ICAM‐1 was significantly downregulated after QGYD combined with LEV treatment. Moreover, the mRNA expressions of TLR4, MyD88, NF‐κB, and ICAM‐1 were significantly downregulated. These results indicated that the mechanism of QGYD restoring LEV susceptibility to MDR PA was related to its regulation of inflammatory cytokines and the TLR4/MyD88/NF‐κB signaling pathway, which provides theoretical support for the clinical application of QGYD combined with LEV therapy to MDR PA infection.